Management of Uncontrolled Hypertension

Current Blood Pressure Assessment

The patient's blood pressure of 140/92 mmHg meets the diagnostic threshold for hypertension and indicates inadequate control on current dual therapy, according to the International Society of Hypertension guidelines 1
This represents stage 1 hypertension, requiring immediate drug treatment intensification rather than waiting for lifestyle modifications alone, as recommended by the International Society of Hypertension 1
The target blood pressure should be <140/90 mmHg minimum, ideally <130/80 mmHg for higher-risk patients, as suggested by the American Heart Association and the International Society of Hypertension 1, 2

The American College of Cardiology recommends adding an ACE inhibitor or ARB to complete the evidence-based triple therapy combination of RAS blocker + calcium channel blocker + thiazide diuretic, for patients with stage 1 hypertension 1
The International Society of Hypertension guidelines specify the treatment sequence for non-Black patients: start with ACE inhibitor/ARB, add calcium channel blocker, then add thiazide diuretic, with a strength of evidence rated as high 1
Triple combination therapy provides complementary mechanisms: volume reduction, vasodilation, and renin-angiotensin system blockade, as recommended by the European Society of Cardiology 2

The American Heart Association recommends confirming medication adherence first, as non-adherence is the most common cause of apparent treatment resistance, with a strength of evidence rated as moderate 2
The International Society of Hypertension suggests verifying blood pressure elevation with home monitoring, with a target confirmation of home blood pressure ≥135/85 mmHg or 24-hour ambulatory blood pressure ≥130/80 mmHg, as recommended by the European Society of Hypertension 1
The American College of Cardiology recommends ruling out secondary hypertension if there are concerning features such as resistant hypertension, young age, or sudden onset, with a strength of evidence rated as high 2

The International Society of Hypertension guidelines suggest that if the patient is Black, the combination of amlodipine + HCTZ may be more effective than adding an ACE inhibitor/ARB, with a strength of evidence rated as moderate 1
The American Heart Association recommends optimizing current doses first: increase HCTZ from 12.5mg to 25mg before adding a third drug class, as recommended by the National Institute for Health and Care Excellence 1
If blood pressure remains uncontrolled after optimizing to amlodipine 10mg + HCTZ 25mg, then add an ARB, as recommended by the American College of Cardiology 1

The European Society of Cardiology recommends adding spironolactone 25-50mg daily as the preferred fourth-line agent for resistant hypertension, provided serum potassium is <4.5 mmol/L and eGFR is >45 ml/min/1.73m², with a strength of evidence rated as high 2
The American Heart Association suggests alternative fourth-line agents if spironolactone is contraindicated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker, as recommended by the International Society of Hypertension 1, 2

The American College of Cardiology recommends not adding a beta-blocker as the third agent unless there are compelling indications, such as angina, post-MI, heart failure with reduced ejection fraction, or need for heart rate control, with a strength of evidence rated as high 1, 2
The International Society of Hypertension suggests not combining ACE inhibitor with ARB, as this increases adverse events without additional benefit, with a strength of evidence rated as high 1, 2
The American Heart Association recommends not delaying treatment intensification, as this patient needs immediate action to reduce cardiovascular risk, with a strength of evidence rated as high 1, 2

The International Society of Hypertension guidelines recommend adding a dihydropyridine calcium channel blocker as the second agent for non-Black patients with uncontrolled hypertension on an ACE inhibitor, before adding a thiazide diuretic 3, 4
The American College of Cardiology recommends a target blood pressure of <130/80 mmHg for most adults, with an initial goal of reducing BP by at least 20/10 mmHg 3, 4

The American Heart Association recommends starting amlodipine 5mg once daily, which can be increased to 10mg daily if blood pressure remains uncontrolled after 2-4 weeks 4, 5
The International Society of Hypertension guidelines recommend continuing lisinopril 40mg once daily, as doses up to 80mg do not appear to give greater effect for hypertension 3, 4

The American College of Cardiology recommends reassessing blood pressure within 2-4 weeks after adding amlodipine to evaluate response 4, 5
The International Society of Hypertension guidelines recommend considering home blood pressure monitoring to confirm office readings and improve medication adherence 3, 5

The American Heart Association recommends sodium restriction to <2g/day, which can provide additive blood pressure reduction of 5-10 mmHg 5, 6
The International Society of Hypertension guidelines recommend weight loss if BMI >25 kg/m², with a target BMI of 20-25 kg/m² 6

The American College of Cardiology recommends referring patients to a hypertension specialist if blood pressure remains ≥160/100 mmHg despite four-drug therapy at optimal doses 4, 6
The International Society of Hypertension guidelines recommend referring patients with suspected secondary hypertension, multiple drug intolerances, or resistant hypertension 4, 6